-
-
-
-
-
-
-
FDA expands EVO ICL age indication to patients 21 to 60 years old
-
-
-
-
-
-
-
BTIG Reiterates Neutral Rating on STAAR Surgical (STAA)
-
-
-
-
-
-
-
ISS recommends STAAR Surgical deal, but warns shareholders have reason to object
-
-
-
-
-
-
-
Yunqi Capital opposes STAAR Surgical merger despite Alcon's raised bid
-
-
-
-
-
-
-
Egan-Jones reaffirms vote against STAAR Surgical sale to Alcon
-
-
-
-
-
-
-
STAAR Surgical amends Alcon merger deal to allow 30-day bidding period
-
-
-
-
-
-
-
STAAR Surgical postpones shareholder vote on Alcon merger to December
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

